INBX 10-Q: SEC filing
Inhibrx Biosciences
Filed with the SEC on · accession 0002007919-26-000059
INBX filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -5.1% by the first close after the filing.
Summary of the filing
Inhibrx Biosciences filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including debt agreements with Oxford Finance and related warrant issuances.
Key details
How INBX stock reacted
Close before
$87.75
Nov 12, 2026
First close after
-5.07%
$83.30
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INBX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INBX?
Click hereFrequently asked questions
What did INBX file with the SEC on Nov 13, 2026?
INBX filed a 10-Q (SEC filing). Inhibrx Biosciences filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including debt agreements with Oxford Finance and related warrant issuances.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did INBX stock react to this filing?
INBX closed at $87.75 before the filing and $83.30 on Nov 13, 2026 (-5.07%).
Other INBX SEC filings
- SCHEDULE 13G/A · SEC filingNov 13, 2026
- 8-K · SEC filingNov 13, 2026
- SCHEDULE 13G/A · SEC filingOct 28, 2026
- 8-K · SEC filingSep 28, 2026
- 8-K · Fda approvalSep 8, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · SEC filingAug 13, 2026
Get alerts when INBX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days